Abstract:The scientific community has been enthusiastic about DNA microarray technology for pharmacogenomic and toxicogenomic studies In the hope of advancing personalized medicine and drug development. The US Food and Drug Administration has been proactive In promoting the use of pharmacogenomic data In drug development and has Issued a draft guidance for the pharmaceutical Industry on data submissions. However, many challenges and pitfalls are facing the microarray community and regulatory agencies before microarray data can be reliably applied to support regulatory decision making. Four types of factors (i.e., technical, Instrumental, computational and Interpretative) affect the outcome of a microarray study, and a major concern about microarray studies has been the lack of reproducibility and accuracy. Intralaboratory data consistency Is the foundation of reliable knowledge extraction and meaningful crosslaboratory or crossplatform comparisons; unfortunately, It has not been seriously evaluated and demonstrated In every study. Profound problems In data quality have been observed from analyzing published data sets, and many laboratories have been struggling with technical troubleshooting rather than generating reliable data of scientific significance. The microarray community and regulatory agencies must work together to establish a set of consensus quality assurance and quality control criteria for assessing and ensuring data quality, to Identity critical factors affecting data quality, and to optimize and standardize microarray procedures so that biologic Interpretation and decision-making are not based on unreliable data. These fundamental Issues must be adequately addressed before microarray technology can be transformed from a research tool to clinical practices.

Gcncchip Technology and Its Application in Pharmacology

Microfluidic Chip Digital PCR Technology and Its Clinical Application

Application of DNA Microarray Technologies in Neurotoxicology Research

Application of the High-throughput Technologies in Preimplantation Genetic Diagnosis

Application of Biochip Technology in Drug Discovery and Development

Application of Microarray Technique in Toxicology

Microarrays: Technologies and Applications

Applications of genechip technology in antineoplastic and cancer treatment

Application of DNA microarray technology in immunological research and its inspiration to researches on traditional Chinese medicine

The Gene Chip Technology and the Prospects of Its Application in Hematology and Oncology

DNA Chip Technology and Its Application

Microarray Applications in Neuroscience

High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research

Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery

PCR gene chips

Biochips :current status and future trends for clinical applications

Application status of pharmacogenomics in clinical researches of new drugs

Dna Microarrays: Applications, Future Trends, And The Need For Standardization

Protein microarrays for studies of drug mechanisms and biomarker discovery in the era of systems biology.

QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies.